moclobemide has been researched along with escitalopram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Kumar, N; Manandhar, S; Moorkoth, S; Pai, KSR; Prathyusha, NS; Sankhe, R; Xue, Y | 1 |
2 other study(ies) available for moclobemide and escitalopram
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies.
Topics: Animals; Antidepressive Agents; Escitalopram; Male; Mice; Mice, Inbred C57BL; Moclobemide; Molecular Docking Simulation; Monoamine Oxidase; Protein Binding; Styrenes; Zingiber officinale | 2021 |